Document Detail


Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation.
MedLine Citation:
PMID:  18036184     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
T(4;14) chromosomal abnormality is one of the most adverse prognostic factors predicting for poor outcome in multiple myeloma (MM) patients. It has been recently suggested that bone disease, as evaluated by spinal magnetic resonance imaging (MRI), is relatively infrequent in these patients. In the present study, we aimed at further testing this hypothesis by analyzing the extent of whole bone involvement in patients showing t(4;14) chromosomal translocation as compared with negative patients. For this purpose, 53 consecutive newly diagnosed MM patients (35M, 18F, median age = 55 yr) underwent evaluation of total skeletal X-ray, whole spine MRI, and at the same time, quantification of markers of bone resorption (urinary N-terminal telopeptide, pyridinoline, deoxypyridinoline, serum crosslaps), and bone formation (bone alkaline phosphatase and osteocalcin) was performed. The presence of IgH/MMSET fusion gene as a surrogate marker for t(4;14), was detected in 11 patients (20.7%), whose clinical characteristics were similar to those observed in t(4;14) negative patients. The type of marrow involvement at spinal MRI (diffuse vs. focal vs. negative) was the same in both groups of patients, even though overt vertebral fractures were more frequently found in t(4;14) positive cases (82% vs. 43%, P = 0.05); in line with this finding, skeletal lesions were more common in t(4;14) positive patients (mean skeletal score = 8.54 +/- 1.36 SE, as compared with 3.42 +/- 0.57 SE in t(4;14) negative cases, P = 0.000). These data were confirmed by the evaluation of serum crosslaps, that were significantly increased in patients with t(4;14) abnormality as compared with negative individuals (10,400 pmol/L +/- 2160 SE vs. 5640 pmol/L +/- 859 SE P = 0.02) Our results indicate that, at variance to what has been previously reported, bone resorption is more prominent in t(4;14) positive patients.
Authors:
Patrizia Tosi; Carolina Terragna; Nicoletta Testoni; Elena Zamagni; Matteo Renzulli; Paola Tacchetti; Elena Montanari; Giulia Perrone; Michela Ceccolini; Annamaria Brioli; Maria C Pallotti; Sante Tura; Michele Baccarani; Michele Cavo
Related Documents :
21195914 - Energy expenditure in chronic kidney disease patients.
8164614 - A longitudinal study of total and regional bone mineral content and biochemical markers...
20978944 - Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis ...
11305084 - Bone mineral density and quantitative ultrasound parameters in patients with klinefelte...
1016824 - The management of the patient with calcium stones.
17061634 - Relative adrenal insufficiency in etomidate-naïve patients with septic shock.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-11-23
Journal Detail:
Title:  European journal of haematology     Volume:  80     ISSN:  1600-0609     ISO Abbreviation:  Eur. J. Haematol.     Publication Date:  2008 Jan 
Date Detail:
Created Date:  2008-01-04     Completed Date:  2008-01-30     Revised Date:  2012-06-05    
Medline Journal Info:
Nlm Unique ID:  8703985     Medline TA:  Eur J Haematol     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  31-6     Citation Subset:  IM    
Affiliation:
Seràgnoli Institute of Hematology and Medical Oncology, Bologna University, Bologna, Italy. ptosi@med.unibo.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Bone Diseases / diagnosis*,  etiology
Bone Resorption / diagnosis*,  etiology
Chromosomes, Human, Pair 14
Chromosomes, Human, Pair 4
Female
Histone-Lysine N-Methyltransferase / genetics
Humans
Male
Middle Aged
Multiple Myeloma / complications*,  genetics*
Receptor, Fibroblast Growth Factor, Type 3 / genetics
Repressor Proteins / genetics
Translocation, Genetic*
Chemical
Reg. No./Substance:
0/Repressor Proteins; EC 2.1.1.43/Histone-Lysine N-Methyltransferase; EC 2.1.1.43/WHSC1 protein, human; EC 2.7.10.1/FGFR3 protein, human; EC 2.7.10.1/Receptor, Fibroblast Growth Factor, Type 3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Global diversity of island floras from a macroecological perspective.
Next Document:  C reactive protein and its determinants in healthy men and women from European regions at different ...